Log in
NASDAQ:ODT

Odonate Therapeutics SEC Filings & 10K Form

$15.04
+0.27 (+1.83 %)
(As of 09/18/2020 12:00 AM ET)
Add
Compare
Today's Range
$14.55
Now: $15.04
$15.10
50-Day Range
$14.77
MA: $26.28
$41.06
52-Week Range
$13.82
Now: $15.04
$46.50
Volume555,143 shs
Average Volume176,063 shs
Market Capitalization$483.19 million
P/E RatioN/A
Dividend YieldN/A
Beta0.58

SEC Filings

Odonate Therapeutics (NASDAQ:ODT) SEC Filings

DateFilerForm TypeView
09/17/2020
3:13 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
3:12 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
3:09 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2020
4:59 PM
Davis Aaron I. (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2020
4:59 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
LEWIS JOSEPH (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2020
8:10 AM
Odonate Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
09/02/2020
3:03 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2020
3:02 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2020
3:00 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2020
3:31 PM
Boxer Capital, LLC (Filed by)
Odonate Therapeutics (Subject)
Form SC 13D/A
09/01/2020
3:30 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
LEWIS JOSEPH (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2020
3:30 PM
Davis Aaron I. (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2020
3:14 PM
Odonate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/01/2020
7:17 AM
Hearne Michael S (Reporting)
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
TANG CAPITAL MANAGEMENT LLC (Reporting)
TANG CAPITAL PARTNERS LP (Reporting)
TANG KEVIN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2020
5:01 AM
Odonate Therapeutics (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
Form SC 13D/A
08/26/2020
4:27 PM
Odonate Therapeutics (Filer)
Form 424B5
08/24/2020
3:01 PM
Odonate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/18/2020
3:03 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2020
3:03 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2020
3:02 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2020
7:08 AM
Odonate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/02/2020
3:22 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
3:20 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2020
7:00 AM
Odonate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2020
3:27 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
3:27 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
3:26 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
7:14 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
7:14 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
7:13 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
7:00 AM
Odonate Therapeutics (Filer)
Form DEF 14A
04/28/2020
7:01 AM
Odonate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/17/2020
3:17 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2020
3:12 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2020
7:01 AM
Odonate Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/05/2020
1:18 PM
FRANKLIN RESOURCES INC (Filed by)
Odonate Therapeutics (Subject)
Form SC 13G/A
01/28/2020
8:57 AM
Odonate Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
12/12/2019
5:24 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
5:23 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
5:22 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
5:21 PM
Douglass Laura L. (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
5:21 PM
Odonate Therapeutics (Issuer)
Rosen Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
5:20 PM
Johnson Craig A (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2019
8:01 AM
Odonate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2019
5:04 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2019
5:03 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2019
5:02 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2019
7:12 AM
Odonate Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/06/2019
7:01 AM
Odonate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2019
3:11 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
3:11 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
3:10 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/20/2019
11:15 PM
Odonate Therapeutics (Filer)
Form EFFECT
10/17/2019
4:46 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2019
4:45 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2019
4:44 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
3:02 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
3:01 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
3:01 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2019
3:40 PM
Odonate Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/27/2019
3:05 PM
Odonate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2019
8:03 PM
Odonate Therapeutics (Issuer)
TIDMARSH GEORGE F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2019
6:24 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2019
6:23 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2019
6:23 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2019
3:17 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
3:12 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
3:11 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2019
3:04 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2019
3:04 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2019
7:30 AM
Odonate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2019
7:01 AM
Odonate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/17/2019
5:53 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2019
5:52 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2019
5:52 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
5:40 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
5:40 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
5:39 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
3:35 PM
Odonate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2019
3:30 PM
Boxer Capital, LLC (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
4:01 PM
Odonate Therapeutics (Filer)
Form 424B5
06/25/2019
4:20 PM
Odonate Therapeutics (Filer)
Form 424B5
06/24/2019
4:00 PM
Odonate Therapeutics (Filer)
Form DEF 14A
06/24/2019
7:00 AM
Odonate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2019
8:43 PM
Hearne Michael S (Reporting)
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
TANG CAPITAL MANAGEMENT LLC (Reporting)
TANG CAPITAL PARTNERS LP (Reporting)
TANG KEVIN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2019
5:49 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2019
5:48 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2019
5:48 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
6:15 PM
Hearne Michael S (Reporting)
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
TANG CAPITAL MANAGEMENT LLC (Reporting)
TANG CAPITAL PARTNERS LP (Reporting)
TANG KEVIN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
4:41 PM
Hearne Michael S (Reporting)
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
TANG CAPITAL MANAGEMENT LLC (Reporting)
TANG CAPITAL PARTNERS LP (Reporting)
TANG KEVIN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
5:05 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
5:05 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
5:04 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2019
6:58 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2019
6:58 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2019
6:57 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2019
7:01 AM
Odonate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/17/2019
3:04 PM
Hearne Michael S (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2019
3:03 PM
O'Connell Joseph P (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2019
3:03 PM
Lemkey John G (Reporting)
Odonate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 9/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.